Surgically induced necrotizing scleritis after pterygium excision and conjunctival autograft

Cornea
M S SridharGullapalli N Rao

Abstract

To report a case of surgically induced necrotizing scleritis (SINS) after pterygium excision and conjunctival autograft. A 55-year-old man presented 2 weeks after excision of primary pterygium with conjunctival autograft in the right eye with severe pain in that eye. He had undergone cataract surgery in that eye 8 months before. The graft was pale and white. The underlying sclera was white and avascular. There was marked inflammation adjacent to the site of surgery and graft. A scraping from the graft surface revealed no organisms in smears, and culture revealed no growth. The conjunctival graft was removed. Amniotic membrane transplantation was performed. After surgery, the amniotic membrane was avascular and pale. Systemic steroid therapy was initiated. Three days after initiation of systemic steroid therapy, the graft became vascularized. Over the next 10 days, the eye quietened, conjunctival and scleral inflammation lessened, and the graft was well accepted. Surgically induced necrotizing scleritis is a rare complication of pterygium excision with conjunctival autograft. A pale graft with underlying avascular sclera and surrounding inflammation should arouse suspicion of this complication.

References

Jan 1, 1992·The British Journal of Ophthalmology·E O'DonoghueP Watson
Jun 1, 1990·Ophthalmology·C J LyonsR J Buckley
Nov 1, 1985·Ophthalmology·K R KenyonM E Hettinger
Aug 1, 1994·Australian and New Zealand Journal of Ophthalmology·A GalanopoulosJ O'Day
Nov 1, 1993·The British Journal of Ophthalmology·B D AllanI J Constable
Mar 1, 1993·Cornea·M P VrabecS H Elsing

❮ Previous
Next ❯

Citations

Apr 19, 2005·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Arno HueberMichael Diestelhorst
May 9, 2007·International Ophthalmology·Uğur E AltiparmakSunay Duman
Jan 17, 2012·International Ophthalmology·Charles O BekibeleOlufunmi Ogun
Oct 25, 2003·Cornea·Rahamim Avisar, Dov Weinberger
Nov 13, 2007·Eye & Contact Lens·Dan Q NguyenPhil Luthert
Aug 16, 2013·Eye & Contact Lens·Kunal SuriChristopher J Rapuano
Jul 29, 2005·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Salomon Esquenazi
Feb 16, 2013·Survey of Ophthalmology·Rishi R DoshiEmmett T Cunningham
Feb 12, 2008·The Ocular Surface·Jeanie ChuiMinas T Coroneo
Dec 18, 2007·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Madhura A Tamhankar, Nicholas J Volpe
Aug 11, 2015·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Sophie BoucherKashif Baig
Sep 12, 2008·Korean Journal of Ophthalmology : KJO·Hyun Ho KimJae Pil Shin
Aug 16, 2016·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Muhsin Eraslan, Ebru Toker
Apr 15, 2014·European Journal of Ophthalmology·Cem KüçükerdönmezYonca Aydin Akova
Dec 3, 2016·The Cochrane Database of Systematic Reviews·Vito RomanoLuigi Fontana
Nov 7, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Heather B JaspanUNKNOWN HIV Vaccine Adolescent Trials Working Group
Oct 4, 2019·Lasers in Surgery and Medicine·Yan WangYan Yu
Jan 1, 2015·Taiwan Journal of Ophthalmology·Yun-Wen ChenPo-Chiung Fan
Jun 28, 2005·Journal of Pediatric Ophthalmology and Strabismus·Tze LaiDinesh Selva
Jun 15, 2021·Ocular Immunology and Inflammation·Sepehr FeiziAhmad Kheirkhah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.